MedTrace Logo

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

NCT03596398 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-07-23

No results posted yet for this study

Summary

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

Conditions

Interventions

GENETIC

GLA gene

Genetic test will be performed when enzyme activity is found abnormal in the whole blood test or confirmation is required. 5 ml of blood sample will be obtained and polymerase chain reaction (PCR) sequencing will be executed to determine mutations in the GLA gene.

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Chiayi Christian Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-09-30
Completion
2022-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03596398 on ClinicalTrials.gov